“Lymphoma red flag”的搜索结果，显示 221-230 项，共有 9076 项

1. 淋巴瘤- 医生与科室- 妙佑医疗国际

   Multiple myeloma, Non-Hodgkin lymphoma, Hodgkin lymphoma, Small lymphocytic lymphoma, B-cell lymphoma, T-cell lymphoma,... Follicular lymphoma ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

4. 妙佑医疗国际 - 什么是淋巴瘤？专家解释

   祝您健康！ Share · Tweet; WeChat. WeChat. Close. Weibo. Aug. 27, 2022 . VID-20522470. 主页; Lymphoma expert backgrounder. 一份馈赠，无穷力量——今天就来伸出援手！

5. 淋巴瘤- 医生与科室- 妙佑医疗国际

   ... lymphoma, Hodgkin lymphoma, Cutaneous t-cell lymphoma, Sezary s...yndrome, B-cell lymphoma, Burkitt lymphoma, Follicular lymphoma, T-cell lymphoma. 显示更多 ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a ...

7. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a ...

8. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

9. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...